6,678 trials
Post-Operative Nausea and Vomiting
Primary: Number of Patients With no Vomiting — 61; 69 participants
Hypertension
Primary: Change From Baseline in Mean Sitting Systolic Blood Pressure (MSSBP) at Week 8 — 167.08; 167.41; 130.73; 137.87 mmHg
Hepatitis A · Hepatitis B
Primary: Number of Subjects Seropositive for Anti-hepatitis A Virus Antibodies (Anti-HAV) and Anti-hepatitis B Surface Antigen (Anti-HBs) Antibodies and With Anti-HBs Antibody…
Bipolar Disorder
Primary: Proportion of Participants Not Experiencing Relapse to Any Mood Episode Through Week 52, Phase 3 — 1.00; 1.00; 0.95; 0.96 proportion of participants — p=0.014
Normal Healthy Subject Population
Primary: The Mean Percent Time Gastric pH > 4.0 on Day 1
Hypertension
Primary: Mean Seated Trough Cuff Systolic Blood Pressure (SBP) at Week 12 — -10.1; -7.3 mmHG
Tonsillitis
Primary: Time to First Morphine Dose — 19; 43.7; 61.1; 137.6 minutes
Diabetes Mellitus, Type 2
Primary: Percentage of Patients Achieving Glycosylated Hemoglobin A1c (HbA1c) < 7.0% at Week 60 (Lantus/Apidra-3 Versus Novolog Mix 70/30 - Intent To Treat (ITT) Population…
Otitis
Primary: Incidence of Pain — 6; 11; 7; 18 participants
Pompe Disease · Glycogen Storage Disease Type II (GSD-II) · Glycogenesis 2 Acid Maltase Deficiency
Primary: Participants' Efficacy Response During the Treatment Period as Compared to Baseline for Participants With Respiratory Decline on Standard Treatment — 0; 0; 0; 1…
Plaque Psoriasis
Primary: Percentage of Subjects Who Achieve Psoriasis Area and Severity Index (PASI) 75 at Week 16 — 22.4; 44.9 Percentage of Subjects — p=0.032
Rheumatoid Arthritis
Primary: Reliability of the European League Against Rheumatism - Rheumatism Arthritis Impact of Disease (EULAR-RAID) Score — 0.85 intraclass correlation coefficient — p=0.000
Nasolabial Folds
Primary: Procedural Pain Score — 2.0; 4.1 units on a scale
Acute Bronchial Obstruction, Asthma
Primary: Mean Change in Maximum Expiratory Flow From Baseline to Final Evaluation — 44; 43.67 Liters/minute
Disorder Related to Cardiac Transplantation
Primary: Change in Measured Glomerular Filtration Rate (mGFR) From Baseline to Month 12 — 48.6; 48.0; 53.2; 47.5 mL/min